Statistics
Publications
3
Citations
46
H-Index
3
Active since
2021
Yingxuan Mao is an author at Harbin Medical University specializing in pi3k signaling, pharmacology, and oncology.
Publications per year
2021–2023
3
3
Triptonide inhibits growth and metastasis in HCC by suppressing EGFR/PI3K/AKT signaling
Hao Zhang, Yingxuan Mao, Xiaomeng Zou et al. · Neoplasma · 2023 · 10 citations · Full text
Medicine, Oncology, Pharmacology +17
1–3 of 3